✦ LIBER ✦

Effects of bosentan on nondigital ulcers in patients with systemic sclerosis

✍ Scribed by T. Taniguchi; Y. Asano; M. Hatano; Z. Tamaki; M. Tomita; T. Kawashima; M. Miyazaki; H. Sumida; K. Akamata; T. Takahashi; Y. Ichimura; T. Toyama; M. Sugita; S. Noda; A. Yao; K. Kinugawa; S. Sato

Book ID: 108671971
Publisher: John Wiley and Sons
Year: 2011
Tongue: English
Weight: 421 KB
Volume: 166
Category: Article
ISSN: 0007-0963
DOI: 10.1111/j.1365-2133.2011.10581.x

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Bosentan for digital ulcers in patients

Bosentan for digital ulcers in patients with systemic sclerosis

✍ Yayoi NAGAI; Michiko HASEGAWA; Tomoyasu HATTORI; Etsuko OKADA; Osamu TAGO; Osamu 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 French ⚖ 278 KB

No effects of bosentan on microvasculatu

No effects of bosentan on microvasculature in patients with limited cutaneous systemic sclerosis

✍ Martha E. Hettema; Dan Zhang; Ymkje Stienstra; Andries J. Smit; Hendrika Bootsma 📂 Article 📅 2009 🏛 Springer 🌐 English ⚖ 178 KB

Digital ulcers in systemic sclerosis: Pr

Digital ulcers in systemic sclerosis: Prevention by treatment with bosentan, an oral endothelin receptor antagonist

✍ J. H. Korn; M. Mayes; M. Matucci Cerinic; M. Rainisio; J. Pope; E. Hachulla; E. 📂 Article 📅 2004 🏛 John Wiley and Sons 🌐 English ⚖ 146 KB 👁 2 views

## Abstract ## Objective Recurrent digital ulcers are a manifestation of vascular disease in patients with systemic sclerosis (SSc; scleroderma) and lead to pain, impaired function, and tissue loss. We investigated whether treatment with the endothelin receptor antagonist, bosentan, decreased the

Successful treatment of systemic scleros

Successful treatment of systemic sclerosis-related digital ulcers and sarcoidosis with endothelin receptor antagonist (bosentan) therapy

✍ J. Tillon; F. Hervé; D. Chevallier; J-F. Muir; H. Levesque; I. Marie 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 560 KB

Drug eruption due to bosentan in a patie

Drug eruption due to bosentan in a patient with systemic sclerosis

✍ Yayoi Nagai; Masayoshi Yamanaka; Shigeru Nishimura; Akihiko Nakano; Akira Hasega 📂 Article 📅 2006 🏛 Springer 🌐 English ⚖ 289 KB

Endothelin receptor antagonist bosentan

Endothelin receptor antagonist bosentan improves the dermal sclerosis in a patient with systemic sclerosis

✍ Akiko Nishibu; Erika Sakai; Noritaka Oyama; Toshiyuki Yamamoto 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 328 KB